PFIZER AND BIONTECH ANNOUNCE VACCINE CANDIDATE AGAINST COVID-19 ACHIEVED SUCCESS IN FIRST INTERIM ANALYSIS FROM PHASE 3 STUDY

View source version on?businesswire.com:?https://www.businesswire.com/news/home/20201109005539/en/
Pfizer Contacts: Media Relations Amy Rose +1 (212) 733-7410 Amy.Rose@pfizer.com? Investor Relations Chuck Triano +1 (212) 733-3901 Charles.E.Triano@Pfizer.com? BioNTech Contacts: Media Relations Jasmina Alatovic +49 (0)6131 9084 1513 or +49 (0)151 1978 1385 Media@biontech.de? Investor Relations Sylke Maas, Ph.D. +49 (0)6131 9084 1074 Investors@biontech.de Source: Pfizer Inc.